M35.9 captures systemic connective tissue involvement when the clinical picture does not meet criteria for — or cannot yet be differentiated into — a named disorder such as lupus, scleroderma, Sjögren syndrome, or mixed connective tissue disease. Applicable-To notes include 'Autoimmune disease (systemic) NOS' and 'Collagen (vascular) disease NOS.'

Documentation tips

What should appear in the chart to support M35.9.

Source · Editorial brief grounded in 6 cited references ↓

• State explicitly why a specific CTD cannot be assigned — e.g., 'serologies inconclusive; does not yet meet ACR criteria for SLE or scleroderma' — to justify use of an unspecified code and withstand payer audit.
• Record all positive and negative serologic findings (ANA titer and pattern, anti-dsDNA, anti-Sm, anti-U1 RNP, anti-SSA/SSB, anti-Scl-70) to support the undifferentiated classification and anchor medical necessity.
• Document every organ system affected — joints, skin, lungs, kidneys, vascular — and assign separate ICD-10-CM codes for each manifestation to capture the correct CC/MCC tier in MS-DRG 545/546/547.
• Note functional impact and limitations (ADL restrictions, work capacity) to establish medical necessity for ongoing rheumatology management, physical therapy, or further diagnostic workup.
• At each follow-up encounter, document whether the condition remains undifferentiated or has evolved toward a named CTD; stagnant chart language without clinical reassessment is an audit red flag.

Related CPT procedures

Procedure codes commonly billed with M35.9. Linking the right diagnosis to the right procedure is what establishes medical necessity.

Source · CMS LCDs · AAOS specialty guidance · claims-pattern analysis

Common coding pitfalls

The recurring mistakes coders make with M35.9 and adjacent codes.

Source · Editorial brief grounded in CDC ICD-10-CM tabular guidance, AAOS coding references, and cited references ↓

• Defaulting to M35.9 when a more specific M35 sibling applies — always check M35.0 through M35.8x before landing on the unspecified code; skipping this step is the most common audit trigger in this category.
• Failing to separately code organ-system manifestations (e.g., I27.0 for pulmonary hypertension, J84.9 for ILD, I73.00 for Raynaud's) causes DRG undercapture and understates clinical severity.
• Using M35.9 when the record actually documents a definitive diagnosis such as SLE (M32.x), systemic sclerosis (M34.x), or dermatomyositis (M33.x) — provider shorthand like 'autoimmune disease' must be queried if a specific CTD diagnosis exists elsewhere in the chart.
• Omitting an query to the provider when documentation says 'lupus' without further qualification — M35.9 is not the correct home for systemic lupus erythematosus; that belongs in the M32 category.
• Carrying M35.9 indefinitely without reassessment documentation; repeated unspecified coding without updated clinical rationale can trigger payer medical necessity denials.

Clinical context

Source · Editorial summary grounded in 6 cited references ↓

Inclusion & exclusion notes

Per the official ICD-10-CM Tabular List.

Source · CDC ICD-10-CM Official Tabular List · 2026

Sibling codes

Other billable codes under M35 (laterality / anatomic variants).